2022
DOI: 10.1002/ajmg.a.62853
|View full text |Cite
|
Sign up to set email alerts
|

Brain cell signaling abnormalities are detected in blood in a murine model of Fragile X syndrome and corrected by Sigma‐1 receptor agonist Blarcamesine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…The effects of opioid-like peptides in the context of FXS remain to be determined. The kappa opioid and sigma-1 non-opioid receptors are under investigation as therapeutic targets for FXS [ 115 , 116 , 117 ].…”
Section: Discussionmentioning
confidence: 99%
“…The effects of opioid-like peptides in the context of FXS remain to be determined. The kappa opioid and sigma-1 non-opioid receptors are under investigation as therapeutic targets for FXS [ 115 , 116 , 117 ].…”
Section: Discussionmentioning
confidence: 99%